XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells
Metrics: PDF 648 views | HTML 1072 views | ?
Honglei Jin1,2, Jiheng Xu2, Xirui Guo2, Haishan Huang1, Jingxia Li2, Minggang Peng2, Junlan Zhu2, Zhongxian Tian2, Xue-Ru Wu3,4,5, Moon-Shong Tang2, Chuanshu Huang1,2
1Zhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
2Nelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA
3Department of Urology, New York University School of Medicine, New York, NY 10016, USA
4Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
5VA Medical Center in Manhattan, New York, NY 10010, USA
Chuanshu Huang, email: firstname.lastname@example.org
Keywords: bladder cancer transformation, XIAP, RING domain, p63α
Received: March 02, 2016 Accepted: June 13, 2016 Published: July 18, 2016
The X-linked inhibitor of apoptosis protein (XIAP) contains three N-terminal BIR domains that mediate anti-apoptosis and one C-terminal RING finger domain whose function(s) are not fully defined. Here we show that the RING domain of XIAP strongly inhibits the expression of p63α, a known tumor suppressor. XIAP knockdown in urothelial cells or RING deletion in knockin mice markedly upregulates p63α expression. This RING-mediated p63α downregulation is critical for the malignant transformation of normal urothelial cells following EGF treatment. We further show that the RING domain promotes Sp1-mediated transcription of miR-4295 which targets the 3’UTR of p63α mRNA and consequently inhibits p63α translation. Our results reveal a previously unknown function of the RING of XIAP in promoting miR-4295 transcription, thereby reducing p63α translation and enhancing urothelial transformation. Our data offer novel insights into the multifunctional effects of the XIAP RING domain on urothelial tumorigenesis and the potential for targeting this frequently overexpressed protein as a therapeutic alternative.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.